Bank of America
NEXI

Bank of America’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Bank of America’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7
Closed -$19 – 8571
2024
Q2 		$19 Buy
+7
New +$24 ﹤0.01% 8018
2023
Q2 		– Sell
-15
Closed -$147 – 8031
2023
Q1 		$147 Buy
15
+13
+650% +$137 ﹤0.01% 7450
2022
Q4 		$12 Buy
+2
New +$25 ﹤0.01% 8065
2022
Q3 		– Sell
-42
Closed -$1.23K – 8301
2022
Q2 		$2K Sell
42
-260
-86% -$16.1K ﹤0.01% 7810
2022
Q1 		$32K Sell
302
-404
-57% -$29.7K ﹤0.01% 7347
2021
Q4 		$81K Buy
706
+583
+474% +$140K ﹤0.01% 6989
2021
Q3 		$47K Buy
123
+56
+84% +$18.8K ﹤0.01% 7076
2021
Q2 		$27K Sell
67
-368
-85% -$170K ﹤0.01% 7054
2021
Q1 		$208K Buy
+435
New +$237K ﹤0.01% 6009

Other funds holding NEXI

RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bank of America's NEXI Position: Q3 2024 in Review

Bank of America sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2024, closing a stake of 7 shares — an estimated $19 sold.

Bank of America first reported a position in NEXI in Q1 2021 and held it in 9 quarters. The position peaked at $208K in Q1 2021. 1 fund tracked by Wall St. Rank holds NEXI as of Q3 2024.

  • Bank of America reported no remaining NexImmune, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Bank of America sold 7 NexImmune, Inc. Common Stock shares in Q3 2024, an estimated $19.
  • Bank of America first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Bank of America's NexImmune, Inc. Common Stock position peaked at $208K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.